PLA2R1 and nephrotic syndrome: This combined treatment led to complete remission of nephrotic syndrome (with the protein-to-creatinine ratio dropping from 8 to 0.3 g/g) and the achievement of negative anti-PLA2R autoantibodies after 8 weeks.